Costs of Gastrointestinal Bleeding Events in Atrial Fibrillation: A Uk Clinical Practice Research Datalink Study
Author(s) -
Sreeram V Ramagopalan,
Mihail Samnaliev,
Sharada Weir,
Cormac Sammon,
Robert Carroll,
Raza Alikhan
Publication year - 2019
Publication title -
future cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.392
H-Index - 33
eISSN - 1744-8298
pISSN - 1479-6678
DOI - 10.2217/fca-2019-0033
Subject(s) - medicine , atrial fibrillation , gastrointestinal bleeding , cardiology , clinical practice , major bleeding , emergency medicine , intensive care medicine , physical therapy
Aim: To estimate the healthcare costs attributable to gastrointestinal (GI) bleeds in nonvalvular atrial fibrillation (NVAF) patients. Material & methods: A difference-in-differences approach was used in which NVAF patients suffering a (GI) bleed were propensity score matched to those not suffering a GI bleed, and the difference in healthcare costs in the year prior to the GI bleed and the subsequent 3 years was compared between the two groups. Results: The mean cost attributable to GI bleeds was £3989 (p < 0.0001) in the year of the bleed and £1816 (p = 0.001) in the subsequent year. Attributable costs arose primarily from inpatient visits. Conclusion: GI bleeds among NVAF patients are associated with significant healthcare costs up to 2 years following the bleed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom